Adocia (France)

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study

Tim Heise, Grégory Meiffren, Bertrand Alluis et al. · Diabetes Obesity and Metabolism · 2018 · 41 citations

Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations

Daniel Weinbuch, Jason K. Cheung, Jurgen Ketelaars et al. · Pharmaceutical Research · 2015 · 37 citations · Full text

Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes

Grit Andersen, Grégory Meiffren, Daniela Lamers et al. · Diabetes Obesity and Metabolism · 2018 · 37 citations · Full text

EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion

Bruno Blanchi, Marion Taurand, Claire Sauty-Colace et al. · Molecular Metabolism · 2023 · 35 citations · Full text

ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes

Grit Andersen, Grégory Meiffren, Susanne Famulla et al. · Diabetes Obesity and Metabolism · 2020 · 27 citations